Breast Biopsy Devices Market

Industry Overview

A breast biopsy is a procedure that involves surgical removal of tissue or fluid to determine the presence of a disease. It requires the guiding system to locate an abnormality in the breast region. The Global Breast Biopsy Devices Market is growing at a significant rate, due to the mounting occurrence of breast cancer among women and the escalating number of breast cancer screening programs. Different types such as needle breast biopsy and open surgical breast biopsy contributed to the breast biopsy devices market size. The market has witnessed a high demand for needle breast biopsy due to the need for a scar-less and painless procedure.

Breast biopsy indicates a specific process in which tissue or fluid is removed surgically to test the presence of any disease in the breast region. A specific guiding system is needed to detect any anomalies. The process helps in accurate diagnosis and distinguishes between benign and malignant situations. This information is very helpful for doctors as it guides them to make the best treatment decisions and timely initiation of the necessary therapies such as surgery, radiation, or chemotherapy.

The global breast biopsy devices market is growing at a significantly high CAGR due to the growing incidence of breast cancer as well as the number of screening programs. There are different types of biopsies done such as needle breast biopsy and open surgical breast biopsy, where the former has a higher demand being a scarless and painless process.

One of the most significant challenges faced by the global breast biopsy device market is the strict and often indeterminate regulatory guidelines regarding the devices. However, growth opportunities are offered by the rising incidents of breast cancer that need proper diagnosis and screenings for early detection and time intervention.

Market Segmentation

Insight by Product

The global breast biopsy devices market is segmented based on product into biopsy needles, guidance systems, localization wires, biopsy tables, and others. Out of all these segments, the biopsy needles segment is expected to account for a larger market share during the forecast period due to higher adoption and higher preference for a painless and scarless procedure.

Insight by Type

The global breast biopsy devices market is segmented based on different types into needle breast biopsy and open surgical breast biopsy, where the former is expected to grow at a faster rate during the forecast period due to higher patient comfort and a painless process. This specific segment is further subdivided into fine-needle aspiration biopsy (FNAB), vacuum-assisted biopsy (VAB), and core-needle biopsy (CNB) sections. Out of these subsections, the VAB segment is expected to grow at a higher CAGR due to a growing preference for a less invasive process. The FNAB segment is also expected to grow significantly due to higher demand for minimally invasive procedures.

Insight by Guidance Techniques

The global breast biopsy devices market is segmented based on application into mammography-guided stereotactic, MRI-guided, ultrasound-guided, and other segments. Out of all these guidance techniques, the ultrasound-guided segment is expected to grow at the fastest rate during the projected period due to growing demand for non-radiation and minimally invasive breast biopsy procedures.

Insight by End User

The global breast biopsy devices market is segmented based on the varied end-users into diagnostic centers, hospitals, and other segments. Among all these segments the diagnostic center segment is expected to contribute a larger share to the market due to higher adoption and the rising number of biopsies performed by these facilities.

Global Breast Biopsy Devices Market Report Coverage

Report Metric	Details
Historical Period	2018 - 2023
Base Year Considered	2024
Forecast Period	2025 - 2030
Market Size in 2023	U.S.D.  xx.x Billion
Revenue Forecast in 2030	U.S.D.  xx.x Billion
Growth Rate	x.x%
Segments Covered in the Report	By Product, By Type, By Guidance Techniques and By End User
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	North America, Europe, Asia-Pacific, Middle East, South America and Rest of the World

Industry Dynamics

Industry Trends

A notable trend in the global breast biopsy devices market is the development of liquid biopsy. In addition, there is also a growing trend among the manufacturers of the products to invest more on research and development of their products to enhance their efficiency along with the continual launch of newer and better products. In addition, integrating advanced imaging technologies such as ultrasound and Magnetic Resonance Imaging for accurate targeting of suspicious lesions as well as rising automation in biopsy devices are other significant trends.

Growth Drivers

The significant technological advancements in breast imaging devices have propelled the growth of the global breast biopsy devices market. In addition, the growing awareness among women regarding breast cancer and the higher preference for minimally invasive biopsies and surgeries are also facilitating the growth of the market. Apart from that, the supportive and convenient reimbursement policies for breast biopsy procedures, especially in the US, also push the market northward. Another significant factor that influences the growth of the market is the growing aging women population.

Challenges

The high cost of these procedures poses a significant challenge to the growth of the global breast biopsy devices market. In addition, the prevailing concern over the potential risks of infection due to breast biopsy procedure also prevents widespread adoption and hinders the growth of the market. Also, the requirement to comply with stringent regulatory standards as well as the high capital requirement poses a major entry barrier and market expansion.

Opportunities

Rapid technological advancements and continual innovation offer significant growth opportunities to the global breast biopsy devices market. In addition, the growing preference for minimally invasive biopsy procedures due to comfort and convenience, rising healthcare investments, and government initiatives to promote awareness programs are creating novel growth opportunities.

Geographic Overview

North America is the largest contributor to the breast biopsy devices market due to the rising occurrence of breast cancer. It is also attributed to technological developments and the growing awareness of the same among women. In addition, the rising cost of healthcare as well as the growing women's aging population also surge the North American breast biopsy devices market.

The Asia-Pacific market is expected to grow at a faster rate during the forecast period due to the rise in the number of breast cancer patients, the growing aging population as well as a large population base. In addition, the growing awareness of these programs and the benefits of screening programs are also propelling the market growth in this region.

Competitive Insight

Key players in the breast biopsy devices market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. Becton, Dickinson and Company, Cook Medical Incorporated, Hologic Inc., Medtronic PLC., Sterylab S.R.L., Danaher Corporation, Siemens AG, Intact Medical Corporation, and Planmed Oy are the key players offering breast biopsy devices.

Cook Group Incorporated is an American privately held company based in Bloomington, Indiana, and primarily involved in manufacturing of medical devices.

Becton, Dickinson and Company is also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies. 

Recent Developments by Key Players

Becton Dickinson (BD) Korea said it has completed Bard Korea's acquisition and integrated its Korean legal entity into BD Korea. However, the two companies have been operating as independent corporations in Korea until now.

The Breast Biopsy Devices Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Product
  • Biopsy needles
  • Guidance systems
  • Localization wires
  • Biopsy tables
  • Others
• By Type
  • Needle breast biopsy
  • Open surgical breast biopsy
• By Guidance Techniques
  • Mammography-guided stereotactic
  • MRI-guided
  • Ultrasound-guided
  • Other guidance techniques
• By End User
  • Diagnostic center
  • Hospitals
  • Others

Geographical Segmentation

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research